Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Biomedicines|March 28, 2026
A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR<sup>+</sup> Breast CancerKeyang Qian, Zijie Cai, Ruiquan Liu, et al.Cancers|May 13, 2026
NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast CancerNianqiu Liu, Mengdi Zhu, Zijie Cai, et al.Nature Communications|November 3, 2020
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancerQianfeng Shi, Yudong Li, Shunying Li, et al.Science China. Life Sciences|August 18, 2022
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitorsZijie Cai, Jingru Wang, Yudong Li, et al.Oncotarget|October 31, 2015
Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancerJiancheng Wang, Yingnan Wang, Shaochuan Wang, et al.Science China. Life Sciences|September 2, 2025
circSCAP-encoded SCAP-129aa mediates platinum resistance in triple-negative breast cancer via the PI3K/AKT pathwayQi Wang, Yudong Li, Zhuangqiu Yang, et al.Science Advances|October 6, 2023
LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 proteinZijie Cai, Qianfeng Shi, Yudong Li, et al.International Journal of Biological Macromolecules|May 3, 2026
3D-printed cell-free bioactive scaffolds from methacrylated hyaluronic acid and silk fibroin incorporating platelet-rich plasma for adipose tissue regenerationWang Yang, Ruiquan Liu, Keyang Qian, et al.Journal of the National Cancer Institute|June 4, 2024
Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancerJinna Lin, Yiye Ouyang, Yudong Li, et al.JCO Precision Oncology|September 14, 2020
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant ChemotherapyShunying Li, Hongna Lai, Jieqiong Liu, et al.Pageof 3